Skip to main content
Erschienen in: Obesity Surgery 7/2020

11.03.2020 | Original Contributions

Management of Acute Gastric Remnant Complications After Roux-en-Y Gastric Bypass: a Single-Center Case Series

verfasst von: Pouya Iranmanesh, Naveen V. Manisundaran, Kulvinder S. Bajwa, Nirav C. Thosani, Melissa M. Felinski, Erik B. Wilson, Shinil K. Shah

Erschienen in: Obesity Surgery | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Roux-en-Y gastric bypass is a common bariatric procedure. Its configuration creates an excluded gastric remnant, which is subject to potential acute complications such as bleeding, perforation, and necrosis.

Material and Methods

A retrospective analysis of a prospective database including all patients presenting between 2007 and 2019 to our institution with acute gastric remnant complications after RYGB was performed.

Results

Seven patients were included, including 3 hemorrhages, two of which were treated with double-balloon enteroscopy, as well as 3 perforations and 1 necrosis, all of which required emergent surgery. Overall gastric remnant complication rate was 0.3% in this series.

Conclusion

Acute gastric remnant complications after RYGB are infrequent, but their diagnosis and management can be challenging. Double-balloon enteroscopy has diagnostic and therapeutic value for selected patients. Emergent surgery remains the standard of care for unstable patients and should not be delayed.
Literatur
1.
Zurück zum Zitat NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.CrossRef
2.
Zurück zum Zitat Buchwald H, Consensus Conference Panel. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005;1(3):371–81.CrossRef Buchwald H, Consensus Conference Panel. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005;1(3):371–81.CrossRef
4.
Zurück zum Zitat Mala T. The gastric remnant in Roux-en-Y gastric bypass: challenges and possibilities. J Clin Gastroenterol. 2016;50(7):527–31.CrossRef Mala T. The gastric remnant in Roux-en-Y gastric bypass: challenges and possibilities. J Clin Gastroenterol. 2016;50(7):527–31.CrossRef
5.
Zurück zum Zitat Heneghan HM, Meron-Eldar S, Yenumula P, et al. Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese. Surg Obes Relat Dis. 2012;8(6):729–35.CrossRef Heneghan HM, Meron-Eldar S, Yenumula P, et al. Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese. Surg Obes Relat Dis. 2012;8(6):729–35.CrossRef
6.
Zurück zum Zitat Cave DR. Obscure gastrointestinal bleeding: the role of the tagged red blood cell scan, enteroscopy, and capsule endoscopy. Clin Gastroenterol Hepatol. 3:959–63. Cave DR. Obscure gastrointestinal bleeding: the role of the tagged red blood cell scan, enteroscopy, and capsule endoscopy. Clin Gastroenterol Hepatol. 3:959–63.
7.
Zurück zum Zitat Mehdizadeh S, Ross A, Gerson L, et al. What is the learning curve associated with double-balloon enteroscopy? Technical details and early experience in 6 U.S. tertiary care centers. Gastrointest Endosc. 2006;64(5):740–50.CrossRef Mehdizadeh S, Ross A, Gerson L, et al. What is the learning curve associated with double-balloon enteroscopy? Technical details and early experience in 6 U.S. tertiary care centers. Gastrointest Endosc. 2006;64(5):740–50.CrossRef
8.
Zurück zum Zitat Kitamura RK, Lee J, Katz LB. The management of GI bleeding after gastric bypass surgery. Int J Surg Res Pract. 2015;2:026.CrossRef Kitamura RK, Lee J, Katz LB. The management of GI bleeding after gastric bypass surgery. Int J Surg Res Pract. 2015;2:026.CrossRef
9.
Zurück zum Zitat Roberts KE, Panait L, Duffy AJ, et al. Laparoscopic-assisted transgastric endoscopy: current indications and future implications. JSLS. 2008;12(1):30–6.PubMedPubMedCentral Roberts KE, Panait L, Duffy AJ, et al. Laparoscopic-assisted transgastric endoscopy: current indications and future implications. JSLS. 2008;12(1):30–6.PubMedPubMedCentral
10.
Zurück zum Zitat Tornese S, Aiolfi A, Bonitta G, et al. Remnant gastric cancer after Roux-en-Y gastric bypass: narrative review of the literature. Obes Surg. 2019;29(8):2609–13.CrossRef Tornese S, Aiolfi A, Bonitta G, et al. Remnant gastric cancer after Roux-en-Y gastric bypass: narrative review of the literature. Obes Surg. 2019;29(8):2609–13.CrossRef
11.
Zurück zum Zitat Ohira M, Toyokawa T, Sakurai K, et al. Current status in remnant gastric cancer after distal gastrectomy. World J Gastroenterol. 2016;22(8):2424–33.CrossRef Ohira M, Toyokawa T, Sakurai K, et al. Current status in remnant gastric cancer after distal gastrectomy. World J Gastroenterol. 2016;22(8):2424–33.CrossRef
12.
Zurück zum Zitat ASGE STANDARDS OF PRACTICE COMMITTEE, Evans JA, Muthusamy VR, et al. The role of endoscopy in the bariatric surgery patient. Surg Obes Relat Dis. 2015;11(3):507–17.CrossRef ASGE STANDARDS OF PRACTICE COMMITTEE, Evans JA, Muthusamy VR, et al. The role of endoscopy in the bariatric surgery patient. Surg Obes Relat Dis. 2015;11(3):507–17.CrossRef
13.
Zurück zum Zitat Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21.CrossRef Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21.CrossRef
14.
Zurück zum Zitat Raghavendra RS, Kini D. Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS. 2012;16(3):360–72.CrossRef Raghavendra RS, Kini D. Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS. 2012;16(3):360–72.CrossRef
15.
Zurück zum Zitat Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3:644–7.CrossRef Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3:644–7.CrossRef
16.
Zurück zum Zitat Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis. 2008;4:709–12.CrossRef Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis. 2008;4:709–12.CrossRef
17.
Zurück zum Zitat Peromaa-Haavisto P, Victorzon M. Is routine preoperative upper GI endoscopy needed prior to gastric bypass? Obes Surg. 2013;23:736–9.CrossRef Peromaa-Haavisto P, Victorzon M. Is routine preoperative upper GI endoscopy needed prior to gastric bypass? Obes Surg. 2013;23:736–9.CrossRef
18.
Zurück zum Zitat de Moura Almeida A, Cotrim HP, Santos AS, et al. Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary? Surg Obes Relat Dis. 2008;4:144–9.CrossRef de Moura Almeida A, Cotrim HP, Santos AS, et al. Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary? Surg Obes Relat Dis. 2008;4:144–9.CrossRef
19.
Zurück zum Zitat Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16:932–4.CrossRef Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16:932–4.CrossRef
20.
Zurück zum Zitat Hu X, Tian DY, Cao L, et al. Progression and prognosis of gastric stump cancer. J Surg Oncol. 2009;100(6):472–6.CrossRef Hu X, Tian DY, Cao L, et al. Progression and prognosis of gastric stump cancer. J Surg Oncol. 2009;100(6):472–6.CrossRef
21.
Zurück zum Zitat Lee SB, Kim JH, Kim DH, et al. Clinicopathological characteristics and prognosis of remnant gastric cancer. J Gastric Cancer. 2010;10(4):219–25.CrossRef Lee SB, Kim JH, Kim DH, et al. Clinicopathological characteristics and prognosis of remnant gastric cancer. J Gastric Cancer. 2010;10(4):219–25.CrossRef
22.
Zurück zum Zitat Hata T, Sakata N, Kudoh K, et al. The best surgical approach for perforated gastric cancer: one-stage vs. two-stage gastrectomy. Gastric Cancer. 2014;17(3):578–87.CrossRef Hata T, Sakata N, Kudoh K, et al. The best surgical approach for perforated gastric cancer: one-stage vs. two-stage gastrectomy. Gastric Cancer. 2014;17(3):578–87.CrossRef
23.
Zurück zum Zitat Kennedy TL. Gastric carcinoma and acute perforation. Br Med J. 1951;2(2):1489–92.CrossRef Kennedy TL. Gastric carcinoma and acute perforation. Br Med J. 1951;2(2):1489–92.CrossRef
24.
Zurück zum Zitat Lehnert T, Buhl K, Dueck M, et al. Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol. 2000;26(8):780–4.CrossRef Lehnert T, Buhl K, Dueck M, et al. Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol. 2000;26(8):780–4.CrossRef
25.
Zurück zum Zitat Yuu K, Kawashima H, Toyoda S, et al. Perforated carcinoma in the gastric remnant: a case of conservative treatment prior to successful curative R0 resection. Case Rep Surg. 2016;2016:4091952.PubMedPubMedCentral Yuu K, Kawashima H, Toyoda S, et al. Perforated carcinoma in the gastric remnant: a case of conservative treatment prior to successful curative R0 resection. Case Rep Surg. 2016;2016:4091952.PubMedPubMedCentral
26.
Zurück zum Zitat Tey J, Soon YY, Koh WY, et al. Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(15):25797–805.CrossRef Tey J, Soon YY, Koh WY, et al. Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(15):25797–805.CrossRef
27.
Zurück zum Zitat Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51(3):177–94.CrossRef Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51(3):177–94.CrossRef
28.
Zurück zum Zitat Cho M, Kaidar-Person O, Szomstein S, et al. Laparoscopic remnant gastrectomy: a novel approach to gastrogastric fistula after Roux-en-Y gastric bypass for morbid obesity. J Am Coll Surg. 2007;204(4):617–24.CrossRef Cho M, Kaidar-Person O, Szomstein S, et al. Laparoscopic remnant gastrectomy: a novel approach to gastrogastric fistula after Roux-en-Y gastric bypass for morbid obesity. J Am Coll Surg. 2007;204(4):617–24.CrossRef
29.
Zurück zum Zitat Voellinger DC, Inabnet WB. Laparoscopic Roux-en-Y gastric bypass with remnant gastrectomy for focal intestinal metaplasia of the gastric antrum. Obes Surg. 2002;12(5):695–8.CrossRef Voellinger DC, Inabnet WB. Laparoscopic Roux-en-Y gastric bypass with remnant gastrectomy for focal intestinal metaplasia of the gastric antrum. Obes Surg. 2002;12(5):695–8.CrossRef
30.
Zurück zum Zitat Greenstein AJ, O’Rourke RW. Abdominal pain after gastric bypass: suspects and solutions. Am J Surg. 2011;201(6):819–27.CrossRef Greenstein AJ, O’Rourke RW. Abdominal pain after gastric bypass: suspects and solutions. Am J Surg. 2011;201(6):819–27.CrossRef
Metadaten
Titel
Management of Acute Gastric Remnant Complications After Roux-en-Y Gastric Bypass: a Single-Center Case Series
verfasst von
Pouya Iranmanesh
Naveen V. Manisundaran
Kulvinder S. Bajwa
Nirav C. Thosani
Melissa M. Felinski
Erik B. Wilson
Shinil K. Shah
Publikationsdatum
11.03.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 7/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04537-w

Weitere Artikel der Ausgabe 7/2020

Obesity Surgery 7/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.